• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Arch Med Res . Impact of TRIM5α and TRIM22 Genes Expression on the Clinical Course of Coronavirus Disease 2019

tetano

Editor, Senior Moderator
Arch Med Res


. 2022 Dec 28;S0188-4409(22)00187-4.
doi: 10.1016/j.arcmed.2022.12.010. Online ahead of print.
Impact of TRIM5α and TRIM22 Genes Expression on the Clinical Course of Coronavirus Disease 2019


Rezvan Tavakoli[SUP] 1 [/SUP], Pooneh Rahimi[SUP] 2 [/SUP], Mojtaba Hamidi-Fard[SUP] 2 [/SUP], Sana Eybpoosh[SUP] 3 [/SUP], Delaram Doroud[SUP] 4 [/SUP], Seyed Amir Sadeghi[SUP] 1 [/SUP], Mohammadali Zaheri Birgani[SUP] 1 [/SUP], Mohammadreza Aghasadeghi[SUP] 5 [/SUP], Abolfazl Fateh[SUP] 6 [/SUP]



Affiliations

Abstract

Objective: The innate immune response in humans involves a wide variety of factors, including the tripartite motif-containing 5α (TRIM5α) and 22 (TRIM22) as a cluster of genes on chromosome 11 that have exhibited antiviral activity in several viral infections. We analyzed the correlation of the expression of TRIM5α and TRIM22 with the severity of Coronavirus Disease 2019 (COVID-19) in blood samples of 330 patients, divided into two groups of severe and mild disease, versus the healthy individuals who never had contact with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Methods: The transcription level of TRIM5α and TRIM22 was determined by quantitative real-time polymerase chain reaction (qPCR). The laboratory values were collected from the patients' records.
Results: The expression of both genes was significantly lower in the severe group containing the hospitalized patients than in both the mild group and the control group. However, in the mild group, TRIM22 expression was significantly higher (p <0.0001) than in the control group while TRIM5α expression was not significantly different between these two groups. We found a relationship between the cycle threshold (Ct) value of patients and the expression of the aforementioned genes.
Conclusion: The results of our study indicated that lower Ct values or higher RNA viral load might be associated with the downregulation of TRIM5α and TRIM22 and the severity of COVID-19. Additional studies are needed to confirm the results of this study.

Keywords: Coronavirus disease 2019; Tripartite motif-containing 22; Tripartite motif-containing 5α; cycle threshold value; mild infection; severe infection.
 
Back
Top Bottom